Phase II study of S-1, leucovorin plus bevacizumab in refractory colorectal cancer
Phase 2
- Conditions
- Colorectal cancer
- Registration Number
- JPRN-UMIN000009083
- Lead Sponsor
- Aichi Cancer Center Hospital, Department of Clinical Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patient with symptomatic brain metastases (2) Massive pleural or paricardial effusion, ascites that required drainage (3) Severe proteinuria (4) Severe comorbidity (5) Pregnant or possibly pregnant, and nursing women (6) Other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease control rate assessed by independent review committee
- Secondary Outcome Measures
Name Time Method Disease control rate assessed by investigator, response rate, overall survival, progression free survival, toxicity, QO